Sohliya, Aibannehbok E. L. 2025. “Revumenib: The Newly Approved Food Drug Administration Drug for the Treatment of Relapsed Acute Leukemia With a KMT2A Translocation”. International Journal of Research in Medical Sciences 13 (2):987-88. https://doi.org/10.18203/2320-6012.ijrms20250291.